Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies.
about
Lipoprotein(a) in cardiovascular diseasesThrombosis in ST-elevation myocardial infarction: Insights from thrombi retrieved by aspiration thrombectomyMonocyte Activation in Immunopathology: Cellular Test for Development of Diagnostics and TherapyOxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipidsAngiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.From hypertension to stroke: mechanisms and potential prevention strategies.Loss of Id3 increases VCAM-1 expression, macrophage accumulation, and atherogenesis in Ldlr-/- miceA pro-atherogenic HDL profile in coronary heart disease patients: an iTRAQ labelling-based proteomic approachFunction and Therapeutic Potential of Mesenchymal Stem Cells in Atherosclerosis.The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of AtherosclerosisSpatial differences in the presence of FOXP3+ and GranzymeB+ T cells between the intra- and extravascular compartments in renal allograft vasculopathy.Association of MEF2A gene polymorphisms with coronary artery diseaseT cell-specific overexpression of TGFß1 fails to influence atherosclerosis in ApoE-deficient miceMyocardin regulates vascular smooth muscle cell inflammatory activation and diseaseClonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes.FoxO4 inhibits atherosclerosis through its function in bone marrow derived cells.High Incidence of ACE/PAI-1 in Association to a Spectrum of Other Polymorphic Cardiovascular Genes Involving PBMCs Proinflammatory Cytokines in Hypertensive Hypercholesterolemic Patients: Reversibility with a Combination of ACE Inhibitor and Statin.Atorvastatin Improves Inflammatory Response in Atherosclerosis by Upregulating the Expression of GARP.Delivery of Polymeric Nanoparticles to Target Vascular Diseases.Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosisHyperglycemia and endothelial dysfunction in atherosclerosis: lessons from type 1 diabetes.A Unique Combination of Nutritionally Active Ingredients Can Prevent Several Key Processes Associated with Atherosclerosis In Vitro.Reliability of serum biomarkers of inflammation from repeated measures in healthy individualsVaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis.Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosisNanomedicines for Endothelial Disorders.Major vault protein regulates class A scavenger receptor-mediated tumor necrosis factor-α synthesis and apoptosis in macrophages.Omega-3 Fatty Acid Formulations in Cardiovascular Disease: Dietary Supplements are Not Substitutes for Prescription Products.The risk of atrial fibrillation in patients with gout: a nationwide population-based study.The comparative effects of atorvastatin and quince leaf extract on atherosclerosisAnti-inflammatory therapeutics for the treatment of atherosclerosis.Prognostic value of cystatin C in acute coronary syndromes: enhancer of atherosclerosis and promising therapeutic target.Role of dietary proteins and peptides in cardiovascular disease.Inflammation in atherosclerosis: a cause or a result of vascular disorders?The effects of extracellular matrix proteins on neutrophil-endothelial interaction--a roadway to multiple therapeutic opportunities.The immune system in stroke: clinical challenges and their translation to experimental research.Statins as modulators of regulatory T-cell biology.Design and utilization of macrophage and vascular smooth muscle cell co-culture systems in atherosclerotic cardiovascular disease investigation.Multiplex assay reliability and long-term intra-individual variation of serologic inflammatory biomarkers.Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.
P2860
Q21284797-04C387DA-5D2E-48B5-92B3-C8FE52070301Q26746148-015FCA89-B09F-45AE-940D-9D9E56E51EBDQ26765189-159903E3-27ED-4652-9678-962533DF921CQ28752575-A84449EC-F8D1-477F-84AF-6A8CCFFFCA89Q29347157-2400B685-42F3-4FE4-927E-5D8434689E64Q30407495-5E5DB9AA-DA19-4F95-B758-1AE655C8B892Q30415987-C28E5D52-3230-4E50-8A87-584B1873691BQ33655192-AB8FAC22-DC5F-43B8-AD2D-D0B41BCA180EQ33710719-4C587F50-DCC2-4002-A0DD-EDC215507A8CQ33838927-5518A3BE-DA1E-4B6E-86DC-8DF4424A0E48Q33873655-2647BD57-6EDD-4AE7-9470-369CE0E88501Q34461392-20E0F8CE-3F79-411A-A62E-DB110CE9F835Q35067512-CE35A090-DAA3-4C31-82AD-99D1D1DD1BA3Q35323782-D049452A-E2FA-47FA-8F16-DFFB0599D64BQ35558887-30566163-B3D5-4B1A-BBA7-CB1BA5EB3C3EQ35581071-77775639-FCB7-4B0A-A88E-17B3C9CFF8CFQ35606860-59D64239-9EC6-4268-A9FF-418422535F15Q35639525-B5A2B428-6BAE-4875-959D-477A82CD41B9Q35701214-360BAF6E-6877-46F1-9357-5C6ADF264B0CQ35710262-C4F3FF2E-7986-42CE-9F1F-A2340260D209Q35830289-55216CD8-4CAD-4C40-ABEE-62C74DBCF3D5Q35948024-B54271EF-9B1D-4AB6-ACD0-45DD8E1B5A13Q36083671-5296B2A4-8552-42C9-9E28-8805052B701AQ36279562-88C1762B-89CC-4316-8260-5DA802778A84Q36638113-89A30A17-57AB-4B01-9352-D7ADE921B081Q36651592-16C71A39-4369-4991-A145-A9C265D19B26Q37000659-07FC7A18-A536-4688-ADD2-2EF7CCE0DF2BQ37099337-2B8CBE98-0DEC-40F0-A89A-0E97A50381D2Q37236227-DC78E7DE-8B9D-4177-9700-B5F24AA99515Q37569125-841BAF17-8956-4728-B447-EB6738EDEAE1Q37626768-502B7CFA-7244-4A5C-8494-0D6F616C9ADCQ37878492-1B4C026C-0AFE-477A-82B1-0F347895B987Q37961649-FCF53FF5-EAAA-470C-845C-FFDF0C964399Q37986175-8944FD78-FD56-4FBB-811F-26A831FEE97AQ38021995-A8562C1A-1CBF-4232-B8D2-48FBCD6BAA43Q38106872-261F39BF-27FC-4DC6-8E07-6CF41B90F829Q38162189-ED7D46D4-013C-4FF8-887E-809598F5A6DEQ38247503-ADAAABF6-D519-44B1-A588-334E4BC5244CQ38376871-2AF53BF0-DB01-45C9-ADFC-BAD02D80B18DQ38620803-6A36D394-BDC8-4D16-93B1-D4B547404567
P2860
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies.
@en
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies.
@nl
type
label
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies.
@en
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies.
@nl
prefLabel
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies.
@en
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies.
@nl
P2860
P921
P356
P1476
Treating inflammation in atherosclerotic cardiovascular disease: emerging therapies.
@en
P2093
Göran K Hansson
Roland Klingenberg
P2860
P304
P356
10.1093/EURHEARTJ/EHP477
P577
2009-10-30T00:00:00Z